This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

19 Sep 2014

Baxter Initiates US Voluntary Recall of One Lot of Potassium Chloride Injection Due to Shipping Carton Mislabeling

Baxter International is voluntarily recalling one lot of potassium chloride injection 10 mEq per 100mL, product code 2B0826 to the hospital/pharmacy/nurse level. The recall is being initiated due to a labeling error on the shipping cartons in a single lot, which was identified by three customers. Shipping cartons labeled for this specific lot number of potassium chloride injection may contain units of gentamicin sulfate injection.


Potassium chloride is indicated for treatment of potassium deficiency and administered intravenously. Gentamicin sulfate is an antibacterial drug for intravenous administration.


As both products are packaged in 100 mL containers, have similar code numbers and red labeling on the front panel, there is a potential risk of medication error or delay in therapy for patients that require high concentration potassium chloride.

Related News